179 related articles for article (PubMed ID: 20520817)
21. Salivary Gland Tumors: A Clinicopathologic Analysis From Taipei Veterans General Hospital.
Liao WC; Chih-Chao C; Ma H; Hsu CY
Ann Plast Surg; 2020 Jan; 84(1S Suppl 1):S26-S33. PubMed ID: 31833885
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological analysis of salivary gland tumors over a 15-year period.
Vasconcelos AC; Nör F; Meurer L; Salvadori G; Souza LB; Vargas PA; Martins MD
Braz Oral Res; 2016; 30():. PubMed ID: 26676198
[TBL] [Abstract][Full Text] [Related]
23. Alterations of p16INK4a tumour suppressor gene in mucoepidermoid carcinoma of the salivary glands.
Guo XL; Sun SZ; Wang WX; Wei FC; Yu HB; Ma BL
Int J Oral Maxillofac Surg; 2007 Apr; 36(4):350-3. PubMed ID: 17223311
[TBL] [Abstract][Full Text] [Related]
24. Alterations of p14ARF and p16INK4a genes in salivary gland carcinomas.
Nishimine M; Nakamura M; Kishi M; Okamoto M; Shimada K; Ishida E; Kirita T; Konishi N
Oncol Rep; 2003; 10(3):555-60. PubMed ID: 12684623
[TBL] [Abstract][Full Text] [Related]
25. Aberrant protein expression and promoter methylation of p16 gene are correlated with malignant transformation of salivary pleomorphic adenoma.
Hu YH; Zhang CY; Tian Z; Wang LZ; Li J
Arch Pathol Lab Med; 2011 Jul; 135(7):882-9. PubMed ID: 21732778
[TBL] [Abstract][Full Text] [Related]
26. Concurrent methylation of promoters from tumor associated genes predicts outcome in acute myeloid leukemia.
Hess CJ; Errami A; Berkhof J; Denkers F; Ossenkoppele GJ; Nygren AO; Schuurhuis GJ; Waisfisz Q
Leuk Lymphoma; 2008 Jun; 49(6):1132-41. PubMed ID: 18569637
[TBL] [Abstract][Full Text] [Related]
27. LZTS2 promoter hypermethylation: a potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma.
Shen Z; Lin L; Cao B; Zhou C; Hao W; Ye D
World J Surg Oncol; 2018 Mar; 16(1):42. PubMed ID: 29499699
[TBL] [Abstract][Full Text] [Related]
28. Clinical and molecular features of mucosa-associated lymphoid tissue (MALT) lymphomas of salivary glands.
Toso A; Aluffi P; Capello D; Conconi A; Gaidano G; Pia F
Head Neck; 2009 Sep; 31(9):1181-7. PubMed ID: 19360750
[TBL] [Abstract][Full Text] [Related]
29. Promoter methylation of APC and RAR-β genes as prognostic markers in non-small cell lung cancer (NSCLC).
Feng H; Zhang Z; Qing X; Wang X; Liang C; Liu D
Exp Mol Pathol; 2016 Feb; 100(1):109-13. PubMed ID: 26681652
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of p63 isotypes (DeltaN and TA) in salivary gland neoplasms: biological and diagnostic implications.
Maruya S; Kies MS; Williams M; Myers JN; Weber RS; Batsakis JG; El-Naggar AK
Hum Pathol; 2005 Jul; 36(7):821-7. PubMed ID: 16084953
[TBL] [Abstract][Full Text] [Related]
31. Expression of Hormone Receptors and HER-2 in Benign and Malignant Salivary Gland Tumors.
Can NT; Lingen MW; Mashek H; McElherne J; Briese R; Fitzpatrick C; van Zante A; Cipriani NA
Head Neck Pathol; 2018 Mar; 12(1):95-104. PubMed ID: 28681314
[TBL] [Abstract][Full Text] [Related]
32. Pretreatment Neutrophil-Lymphocyte Ratio in Salivary Gland Tumors Is Associated with Malignancy.
Damar M; Dinç AE; Erdem D; Aydil U; Kizil Y; Eravcı FC; Bişkin S; Şevik Eliçora S; Işik H
Otolaryngol Head Neck Surg; 2016 Dec; 155(6):988-996. PubMed ID: 27436419
[TBL] [Abstract][Full Text] [Related]
33. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.
Yang B; Guo M; Herman JG; Clark DP
Am J Pathol; 2003 Sep; 163(3):1101-7. PubMed ID: 12937151
[TBL] [Abstract][Full Text] [Related]
34. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic screening of salivary gland mucoepidermoid carcinoma identifies hypomethylation of CLIC3 as a common alteration.
Wang Z; Ling S; Rettig E; Sobel R; Tan M; Fertig EJ; Considine M; El-Naggar AK; Brait M; Fakhry C; Ha PK
Oral Oncol; 2015 Dec; 51(12):1120-5. PubMed ID: 26490796
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic alterations in salivary gland tumors.
Dos Santos ES; Ramos JC; Normando AGC; Mariano FV; Paes Leme AF
Oral Dis; 2020 Nov; 26(8):1610-1618. PubMed ID: 31829479
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of O-6-methylguanine-DNA methyltransferase loss in salivary gland carcinomas.
Scesnaite A; Jarmalaite S; Mueller M; Agaimy A; Zenk J; Hartmann A; Iro H; Peters B; Schwarz S; Schneider-Stock R
Head Neck; 2014 Sep; 36(9):1258-67. PubMed ID: 25201059
[TBL] [Abstract][Full Text] [Related]
38. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
39. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D
J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic signatures of familial cancer are characteristic of tumor type and family category.
Joensuu EI; Abdel-Rahman WM; Ollikainen M; Ruosaari S; Knuutila S; Peltomäki P
Cancer Res; 2008 Jun; 68(12):4597-605. PubMed ID: 18559504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
